A Study in Leukemia Patients With Karonudib

NCT04077307 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: Karonudib

Sponsor

Thomas Helleday Foundation